January 21, 2018

Breast Cancer Survivors Invited to Participate in Exercise Study at Yale

The Hormones and Physical Exercise (HOPE) Study, a Yale School of Public Health study, funded by the National Institutes of Health is expanding and women living on the shoreline are being invited to participate.

Women who have been treated for breast cancer and who are taking an aromatase inhibitor (Femara, Aromasin, Arimidex or a generic version) are being invited to participate in this important study.  Aromatase inhibitors are taken by many post-menopausal women who have had breast cancer.

This research study will examine if a program of strength training combined with moderate intensity aerobic exercise improves the side effects from aromatase inhibitors, such as joint pain and bone loss.

Half the women in the study will be chosen at random to start a 12-month exercise program.  The other half will participate in a health education program for 12 months.

The exercise program will be individually tailored to your needs and will include two supervised strength training sessions per week at the Westbrook YMCA and 150 minutes per week of aerobic exercise, such as brisk walking.  A 12-month membership to the YMCA will be provided to those in the exercise group.

The health education program will involve a health counselor telephoning you once a month to discuss topics of interest for women who have had breast cancer.  Upon completion of the 12-month program, an exercise trainer will also develop a personalized exercise program for you.

All costs related to the study will be paid by the HOPE study.  Office visits will be reimbursed with a $20 gas card and payment of all parking charges. If the 12-month study is completed (including attendance at the 6-month office visit), the participant will receive a $50 gift card to Wal-Mart

If you are interested in learning more about the HOPE Study by phone or email, call 203-764-8427 or email the Principal Investigator, Dr Melinda Irwin at melinda.irwin@yale.edu

Click here for more details

Share